Envoy Medical Inc. (COCH) Stock Forecast & Price Target
Envoy Medical Inc. · NASDAQ
$0.68+0.01 (+2.20%)
15-min delayed · Jul 27, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 1 firms covering Envoy Medical Inc, 1 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets are tightly clustered, $2.50 to $2.50, so the covering firms are broadly aligned. The average target of $2.50 sits 269% above the current $0.68. The rating mix has stayed broadly stable, with Buy-side ratings easing from 2 to 1 over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.07 next quarter toward $-0.19 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS1 ratings
Moderate Buy
Strong Buy00%
Buy1100%
Hold00%
Sell00%
Strong Sell00%
Based on 1 analysts giving stock ratings to Envoy Medical Inc.
As of Jul, 1 of 1 firms rate COCH a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
COCH EPS & revenue forecast
EPS · NEXT QUARTER
$-0.07
Range $-0.07 – $-0.07 · 1 analysts · -80% YoY
Next period, 1 analysts expect Envoy Medical Inc. to earn $-0.07 a share (range $-0.07 – $-0.07), versus $-0.35 a year earlier. Full-year consensus is $-0.29, growing to $-0.19 the year after.
REVENUE · NEXT QUARTER
$60.0K
Range $60.0K – $60.0K · 1 analysts · +43% YoY
Revenue is expected to reach $60.0K (range $60.0K – $60.0K), +42.9% year-over-year. Full-year consensus is $219.0K, rising to $240.0K next year.
Top analysts covering Envoy Medical Inc.
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on COCH.
#1
Yi Chen
HC Wainwright & Co. · Rank #238
Buy
$2.50+269.1% to target
Overall win rate
34%
+ Follow
#2
Frank Takkinen
Lake Street · Rank #327
Buy
$6.00+785.9% to target
Overall win rate
26%
+ Follow
#3
Edward Woo
Ascendiant Capital · Rank #358
Buy
$9.50+1302.6% to target
Overall win rate
26%
+ Follow
#4
Carl Byrnes
Northland Capital Markets
Buy
$5.00+638.2% to target
Coverage
—
+ Follow
#5
EW
Edward Woo
Ascendiant
Buy
$9.50+1302.6% to target
Coverage
—
+ Follow
COCH stock forecast FAQ
What is COCH's average 12-month price target?+
The 1 analysts with a live target average $2.50 for Envoy Medical Inc. over the next 12 months, ranging from a $2.50 high to a $2.50 low.
Is COCH stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 1 analyst ratings, 1 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
How many Wall Street analysts cover COCH?+
1 analysts have an active rating on Envoy Medical Inc., and 1 firms carry a live 12-month price target.
Who is the most accurate analyst covering COCH?+
Among analysts who currently cover COCH, Yi Chen of HC Wainwright & Co. has the strongest overall Quantellect track record (Rank #238). Their current call is Buy with a $2.50 target.
What is Envoy Medical Inc.'s projected EPS for next quarter?+
The consensus estimate is $-0.07 per share (range $-0.07 – $-0.07) across 1 analysts. Full-year EPS is projected at $-0.29, rising to $-0.19 the following year.
How much revenue is Envoy Medical Inc. expected to report next quarter?+
Consensus revenue is $60.0K (range $60.0K – $60.0K). Full-year revenue is projected at $219.0K, growing to $240.0K next year.
Have analysts been upgrading or downgrading COCH lately?+
As of Jul, 1 of 1 firms rate COCH a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their COCH calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
